SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-035054
Filing Date
2019-07-18
Accepted
2019-07-18 16:22:59
Documents
3
Group Members
CURT LABELLEPRIVATE MEDICAL EQUITY, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13DA tv525225_sc13da.htm SC 13D/A 97846
2 EXHIBIT 10.1 tv525225_ex10-1.htm EX-10.1 19479
3 EXHIBIT 10.2 tv525225_ex10-2.htm EX-10.2 20016
  Complete submission text file 0001144204-19-035054.txt   138622
Mailing Address 8748 TECHNOLOGY WAY RENO NV 89521
Business Address 8748 TECHNOLOGY WAY RENO NV 89521 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 19961556
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Filed by) CIK: 0001728916 (see all company filings)

Type: SC 13D/A